The gene transfection efficiency of a folate–PEI600–cyclodextrin nanopolymer
Source abstract
Abstract
The success of gene therapy relies on a safe and effective gene delivery system. In this communication, we describe the use of folate grafted PEI(600)-CyD (H(1)) as an effective polyplex-forming plasmid delivery agent with low toxicity. The structures of the polymer and polyplex were characterized, and the in vitro transfection efficiency, cytotoxicity, and in vivo transfection of H(1) were examined. We found that folate molecules were successfully grafted to PEI(600)-CyD. At N/P ratios between 5 and 30, the resulting H(1)/DNA polyplexes had diameters less than 120 nm and zeta potentials less than 10 mV. In various tumor cell lines examined (U138, U87, B16, and Lovo), the in vitro transfection efficiency of H(1) was more than 50%, which could be improved by the presence of fetal bovine serum or albumin. The cytotoxicity of H(1) was significantly less than high molecular weight PEI-25 kDa. Importantly, in vivo optical imaging showed that the efficiency of H(1)-mediated transfection (50 microg luciferase plasmid (pLuc), N/P ratio=20/1) was comparable to that of adenovirus-mediated luciferase transduction (1 x 10(9) pfu) in melanoma-bearing mice, and it did not induce any toxicity in the tumor tissue. These results clearly show that H(1) is a safe and effective polyplex-forming agent for both in vitro and in vivo transfection of plasmid DNA and its application warrants further investigation.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques · Virus-based gene therapy research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (55)
Show source-provided references
1. Development of recombinant adeno-associated virus and adenovirus cocktail system for efficient hTERTC27 polypeptide-mediated cancer gene therapy10.1038/cgt.2008.33 ↗
2. Retroviral vectors. From laboratory tools to molecular medicine10.1007/BF02789062 ↗
3. Molecular basis of the inflammatory response to adenovirus vectors10.1038/sj.gt.3302036 ↗
4. Virus treatment questioned after gene therapy death10.1038/43977 ↗
5. Immune responses to adeno-associated virus and its recombinant vectors10.1038/sj.gt.3302039 ↗
6. Design and development of polymers for gene delivery10.1038/nrd1775 ↗
7. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine10.1073/pnas.92.16.7297 ↗
8. Polyethylenimine-based non-viral gene delivery systems10.1016/j.ejpb.2004.11.011 ↗
9. A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: effect of molecular weight on transfection efficiency and cytotoxicity10.1023/A:1014861900478 ↗
10. Polyethylene glycol modified polyethylenimine for improved CNS gene transfer: effects of PEGylation extent10.1016/S0142-9612(03)00029-2 ↗
11. Repeated intrathecal administration of plasmid DNA complexed with polyethylene glycol-grafted polyethylenimine led to prolonged transgene expression in the spinal cord10.1038/sj.gt.3301970 ↗
12. PEGylated DNA/transferrin–PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery10.1038/sj.gt.3300900 ↗
13. Poly(ethylenimine) and its role in gene delivery10.1016/S0168-3659(99)00090-5 ↗
14. Biodegradable polymers as non-viral carriers for plasmid DNA delivery10.1016/j.jconrel.2007.10.028 ↗
15. Efficient gene transfer using reversibly cross-linked low molecular weight polyethylenimine10.1021/bc0100455 ↗
16. Biodegradable poly(ethylenimine) for plasmid DNA delivery10.1016/S0168-3659(01)00547-8 ↗
17. Poly(ethylenimine-co-l-lactamide-co-succinamide): a biodegradable polyethylenimine derivative with an advantageous pH-dependent hydrolytic degradation for gene delivery10.1021/bc0255135 ↗
18. A degradable polyethylenimine derivative with low toxicity for highly efficient gene delivery10.1021/bc034014g ↗
19. Cyclodextrin-based pharmaceutics: past, present and future10.1038/nrd1576 ↗
20. New class of polymers for the delivery of macromolecular therapeutics10.1021/bc990072j ↗
21. Transferrin-containing, cyclodextrin polymer-based particles for tumor-targeted gene delivery10.1021/bc034125f ↗
22. The size of DNA/transferrin–PEI complexes is an important factor for gene expression in cultured cells10.1038/sj.gt.3300745 ↗
23. Transferrin–polycation–DNA complexes: the effect of polycations on the structure of the complex and DNA delivery to cells10.1073/pnas.88.10.4255 ↗
24. Use of folic acid and delivery outcome: a prospective registry study10.1016/S0890-6238(02)00041-2 ↗
25. Efficient gene delivery via non-covalent complexes of folic acid and polyethylenimine10.1016/S0168-3659(01)00456-4 ↗
26. Distribution, functionality and gene regulation of folate receptor isoforms: implications in targeted therapy10.1016/j.addr.2004.01.001 ↗
27. Low molecular weight polyethylenimines linked by beta-cyclodextrin for gene transfer into the nervous system10.1002/jgm.874 ↗
28. Cell cycle-related kinase: a novel candidate oncogene in human glioblastoma10.1093/jnci/djm011 ↗
29. Degradable polyethylenimine-alt-poly(ethylene glycol) copolymers as novel gene carriers10.1016/j.jconrel.2005.04.008 ↗
30. Characterization of the transgene expression generated by branched and linear polyethylenimine-plasmid DNA nanoparticles in vitro and after intraperitoneal injection in vivo10.1016/j.jconrel.2008.04.014 ↗
31. Lung-directed gene therapy in mice using the nonviral sleeping beauty transposon system10.1038/nprot.2007.460 ↗
32. Optical imaging of transferrin targeted PEI/DNA complexes in living subjects10.1038/sj.gt.3301939 ↗
33. Electrophoretic purification of tumor-targeted polyethylenimine-based polyplexes reduces toxic side effects in vivo10.1016/j.jconrel.2007.05.013 ↗
34. Poly(aspartate-g-PEI800), a polyethylenimine analogue of low toxicity and high transfection efficiency for gene delivery10.1016/j.biomaterials.2007.07.043 ↗
35. Two novel non-viral gene delivery vectors: low molecular weight polyethylenimine cross-linked by (2-hydroxypropyl)-beta-cyclodextrin or (2-hydroxypropyl)-gamma-cyclodextrin10.1039/B601130F ↗
36. Cyclodextrin–polyethylenimine conjugates for targeted in vitro gene delivery10.1002/bit.20356 ↗
37. Cyclodextrin-modified polyethylenimine polymers for gene delivery10.1021/bc049891g ↗
38. Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro10.1016/0005-2736(94)00235-H ↗
39. Synthesis of highly stable folic acid conjugated magnetite nanoparticles for targeting cancer cells10.1088/0957-4484/18/38/385102 ↗
40. In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis10.1016/S0142-9612(02)00445-3 ↗
41. Membrane transport of folates10.1016/S0083-6729(03)01012-4 ↗
42. The role of alpha-folate receptor-mediated transport in the antitumor activity of antifolate drugs10.1158/1078-0432.CCR-03-0157 ↗
43. Molecular cloning and characterization of the human folate-binding protein cDNA from placenta and malignant tissue culture (KB) cells10.1016/S0021-9258(18)63786-X ↗
44. Effect of hyperthermia on intracellular drug accumulation and chemosensitivity in drug-sensitive and drug-resistant P388 leukaemia cell lines10.3109/02656738909140445 ↗
45. Folate-targeted chemotherapy10.1016/j.addr.2004.01.008 ↗
46. Synthesis and characterization of folate-PEG-grafted-hyperbranched-PEI for tumor-targeted gene delivery10.1016/j.bbrc.2008.01.024 ↗
47. Dynamic changes in the characteristics of cationic lipidic vectors after exposure to mouse serum: implications for intravenous lipofection10.1038/sj.gt.3300865 ↗
48. Peters · 1996
49. Folate receptor targeted imaging using poly(ethylene glycol)–folate: in vitro and in vivo studies10.3346/jkms.2007.22.3.405 ↗
50. Methylation of episomal plasmids as a barrier to transient gene expression via a synthetic delivery vector10.1016/S1389-0344(01)00100-9 ↗
51. DNA methylation and viral gene expression in adenovirus-transformed and-infected cells10.1093/nar/8.11.2461 ↗
52. Lack of evidence for methylation of parental and newly synthesized adenovirus type 2 DNA in productive infections10.1128/jvi.56.1.320-324.1985 ↗
53. Quantitative and mechanism-based investigation of post-nuclear delivery events between adenovirus and lipoplex10.1093/nar/gkl1165 ↗
54. Quantitative comparison of intracellular trafficking and nuclear transcription between adenoviral and lipoplex systems10.1016/j.ymthe.2005.10.007 ↗
55. Quantitative comparison of polyethylenimine formulations and adenoviral vectors in terms of intracellular gene delivery processes10.1038/sj.gt.3302495 ↗